Kazia Therapeutics Ltd Sponsored ADR
(NASDAQ : KZIA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.35%197.541.2%$610.29m
GILDGilead Sciences, Inc.
-0.16%67.900.9%$502.40m
CELGCelgene Corporation
-2.97%67.341.2%$478.70m
BIIBBiogen Inc.
0.52%320.871.3%$470.03m
ILMNIllumina, Inc.
-0.09%301.313.5%$381.35m
REGNRegeneron Pharmaceuticals, Inc.
0.15%339.512.6%$299.13m
VRTXVertex Pharmaceuticals Incorporated
-0.75%159.861.9%$258.59m
ALXNAlexion Pharmaceuticals, Inc.
1.63%116.942.0%$202.33m
AAgilent Technologies, Inc.
6.96%66.971.5%$198.93m
SRPTSarepta Therapeutics, Inc.
1.68%118.3215.4%$149.24m
LGNDLigand Pharmaceuticals Incorporated
1.48%150.7423.3%$141.64m
EXASExact Sciences Corporation
-2.58%65.5525.3%$133.50m
TSROTESARO, Inc.
13.49%41.8014.4%$124.15m
NKTRNektar Therapeutics
0.05%38.035.6%$122.31m
INCYIncyte Corporation
-1.07%63.562.5%$114.49m

Company Profile

Kazia Therapeutics Ltd. engages in the pharmaceutical drug development. It involves in preclinical research confirms efficacy of cantrixil which induces cell death in chemoresistant ovarian cancer stem cells. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.